By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Abbott today reported that its first-quarter molecular diagnostics sales increased 6 percent year over year as its total sales were up around 5 percent compared to Q1 2011.

Abbott reported molecular diagnostics sales of $105 million, up from $99 million for the first quarter of 2011. Of that total, $47 million came from the US market and $58 million in sales were derived from international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.